Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting. uri icon

Overview

authors

  • Brener, Sorin Jakob
  • Serruys, Patrick W
  • Morice, Marie-Claude
  • Mehran, Roxana
  • Kappetein, Arie Pieter
  • Sabik, Joseph F
  • Liu, Yangbo
  • Dressler, Ovidiu
  • Ben-Yehuda, Ori
  • Stone, Gregg W

publication date

  • October 23, 2018

Research

keywords

  • Aspirin
  • Coronary Restenosis
  • Drug Therapy, Combination
  • Percutaneous Coronary Intervention
  • Purinergic P2Y Receptor Antagonists
  • Stents

Identity

Scopus Document Identifier

  • 85054181687

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2018.07.084

PubMed ID

  • 30336833

Additional Document Info

volume

  • 72

issue

  • 17